CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Questionnaires +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05634551
NCT05634551N/ACompleted
CompareCT.gov

Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance Status

M.D. Anderson Cancer Center·observational·Posted Dec 2, 2022·Updated Aug 6, 2024

In Brief

An observational study evaluating Questionnaires and Interview for Non-small Cell Lung Cancer. Completed, enrolled 15 participants across 1 site.

Detailed Summary

To better understand your feelings and expectations about immunotherapy

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNon-small Cell Lung Cancer
CountriesUnited States
CollaboratorsConquer Cancer Foundation

Timeline

N/ACompletedFinished
2023202420252026
First PostedDec 2, 2022
Enrollment StartFeb 9, 2023
Primary CompletionAug 2, 2024
TodayJul 1, 2026
Enrollment to primary: 1.5 yearsPosted 3.6 years ago

Interventions

Questionnairesbehavioral

Participants will complete 5 questionnaires about any symptoms participants may be having, any anxiety and/or depression participants may be having, your preference in decision-making, and your expectations about your treatment. It should take about 30 minutes to complete all 5 questionnaires

Interviewbehavioral

The interview will last about 30-45 minutes. The interview will be conducted over the phone or remotely over Zoom or FaceTime (based on your preference)